Thiabendazole for the treatment of strongyloidiasis in patients with hematologic malignancies

Clinical Infectious Diseases

Volumn 31, Issue 3, 2000, Pages 821-822

  Schaffel, R ^a   Nucci, M ^a   Portugal, R ^a   Castro, M B ^a   Ferreira, S B ^a   Almeida, L ^a   Spector, N ^a   Pulcheri, W ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

TIABENDAZOLE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER PATIENT; CLINICAL ARTICLE; FEMALE; HUMAN; LEUKEMIA; LYMPHOMA; MALE; MULTIPLE MYELOMA; PRIORITY JOURNAL; RELAPSE; SCHOOL CHILD; STRONGYLOIDIASIS; VERTIGO;

ADOLESCENT; ADULT; AGED; ANTINEMATODAL AGENTS; CHILD; DIZZINESS; FEMALE; FOLLOW-UP STUDIES; HEMATOLOGIC NEOPLASMS; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; STRONGYLOIDIASIS; THIABENDAZOLE; TREATMENT OUTCOME;

EID: 0034456056     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/314023     Document Type: Article

References (9)

1. Strongyloidiasis
2. Treatment of Strongyloides stercoralis hyperinfection syndrome with thiabendazole administered per rectum
3. Risk factors for strongyloidiasis: A case-control study
4. Diagnosis of strongyloidiasis: Importance of Baermann's method
5. Strongyloidiasis in patients with hematologic malignancies
6. A randomized trial of single- and two-dose ivermectin versus thiabendazole for treatment of strongyloidiasis
7. Treatment of strongyloidiasis with thiabendazole: An analysis of toxicity and effectiveness
8. Treatment of Strongyloides stercoralis infection with ivermectin compared with albendazole: Results of an open study of 60 cases
9. Strongyloidiasis and infection due to human immunodeficiency virus: 25 cases at a Brazilian teaching hospital, including seven cases of hyperinfection syndrome